EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA.
D000970:Antineoplastic Agents; D001388:Aziridines; D001943:Breast Neoplasms; D003520:Cyclophosphamide; D003609:Dactinomycin; D005472:Fluorouracil; D006689:Hodgkin Disease; D006801:Humans; D007414:Intestinal Neoplasms; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin; D008357:Mannomustine; D008654:Mesothelioma; D009101:Multiple Myeloma; D009369:Neoplasms; D010190:Pancreatic Neoplasms; D012509:Sarcoma; D013019:South Africa; D013274:Stomach Neoplasms; D014747:Vinblastine
D000970:Antineoplastic Agents; D001388:Aziridines; D003609:Dactinomycin; D014747:Vinblastine; D003520:Cyclophosphamide; C026480:inproquone; D008357:Mannomustine; D005472:Fluorouracil
ACTINOMYCIN; ANTINEOPLASTIC AGENTS; BAYER E39; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; FLUOROURACIL; HODGKIN'S DISEASE; INTESTINAL NEOPLASMS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; LYMPHOSARCOMA; MANNOMUSTINE; MESOTHELIOMA; MULTIPLE MYELOMA; PANCREATIC NEOPLASMS; SARCOMA; SOUTH AFRICA; STOMACH NEOPLASMS; VINBLASTINE